Affiner la recherche

  • Livres (50)

à

Fourchette de prix personnalisée (EUR)

à

Robert r. nesbitt (50 résultats)

  • Edité par Harvard University Press, 1968

    • Couverture rigide
    • Édition originale

    Vendeur : Katsumi-san Co., Cambridge, MA, Etats-UnisKatsumi-san Co.

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Occasion - Assez bon

    EUR 11,20

    EUR 1,77 expédition 
    Expédition nationale : Etats-Unis

    Quantité disponible : 1 disponible

    Ajouter au panier

    Hardcover. Etat : Very Good. Dust Jacket Included. 1st Edition. Very Good in Poor dust jacket. Top of free front endpaper has former owner's signature and a stamp indicating that this volume was not accessioned by a Harvard University library; bottom of back panel of dust jacket is badly chipped and torn; tight, text clean. xvii, [3], 388 p. [B1:6:4].…

  • Edité par Harvard University Press, 1968

    • Couverture rigide

    Vendeur : Peter L. Masi - books, MONTAGUE, MA, Etats-UnisPeter L. Masi - books

    Vendeur avec une évaluation de 4 étoiles
    Contacter le vendeur

    Membre d’une association professionnelle : SNEAB

    Etat: Occasion - Assez bon

    EUR 9,37

    EUR 4,87 expédition 
    Expédition nationale : Etats-Unis

    Quantité disponible : 1 disponible

    Ajouter au panier

    Hardcover. Etat : Used - Very Good. Harvard University Press, Cambridge, 1968. 388 pages. Illustrated. 9.5 x 6.5", hardcover, no dj. No dj, clean, tight, Very Good/None.

  • Langue : anglais

    Edité par THE CHRISTOPHER PUB. HOUSE, HANOVER, MA, 1999

    0815805314 / 9780815805311

    • Couverture rigide
    • Édition originale

    Vendeur : Gian Luigi Fine Books, albany, NY, Etats-UnisGian Luigi Fine Books

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Occasion - Très bon

    EUR 36,54

    EUR 8,82 expédition 
    Expédition nationale : Etats-Unis

    Quantité disponible : 1 disponible

    Hardcover. Etat : Fine. Etat de la jaquette : Fine. First Edition.

  • Langue : anglais

    Edité par Springer, 2025

    3031982525 / 9783031982521

    • Couverture rigide

    Vendeur : Books From California, Simi Valley, CA, Etats-UnisBooks From California

    Vendeur avec une évaluation de 4 étoiles
    Contacter le vendeur

    Etat: Occasion - Très bon

    EUR 42,50

    EUR 4,54 expédition 
    Expédition nationale : Etats-Unis

    Quantité disponible : 8 disponibles

    hardcover. Etat : Fine.

  • Langue : anglais

    Edité par Springer, 2025

    3031982525 / 9783031982521

    • Couverture rigide

    Vendeur : Books From California, Simi Valley, CA, Etats-UnisBooks From California

    Vendeur avec une évaluation de 4 étoiles
    Contacter le vendeur

    Etat: Occasion - Assez bon

    EUR 42,50

    EUR 4,54 expédition 
    Expédition nationale : Etats-Unis

    Quantité disponible : 8 disponibles

    hardcover. Etat : Very Good.

  • Edité par Harvard University Press

    Vendeur : Robinson Street Books, IOBA, Binghamton, NY, Etats-UnisRobinson Street Books, IOBA

    Vendeur avec une évaluation de 4 étoiles
    Contacter le vendeur

    Membre d’une association professionnelle : IOBA

    Etat: Occasion - Comme neuf

    EUR 18,74

    EUR 8,64 expédition 
    Expédition nationale : Etats-Unis

    Quantité disponible : 1 disponible

    Ajouter au panier

    Etat : As New. Prompt Shipment, shipped in Boxes, Tracking PROVIDED1.

  • Langue : anglais

    Edité par Springer International Publishing AG, Cham, 2025

    3031982525 / 9783031982521

    • Couverture rigide

    Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-UnisGrand Eagle Retail

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 62,86

     Frais de port gratuits 
    Expédition nationale : Etats-Unis

    Quantité disponible : 1 disponible

    Hardcover. Etat : new. Hardcover. This open access book builds the case for the business motivation, techniques, and approaches to use in development of a medicinal product for human therapy, whether delivered via an oral dose form (pill or solution) or a delivery system (device). It shares the growing demands by patients and caregivers, as well as regulators, for designs which are most easily understood and usable, and which can ensure the medication can be consistently delivered and will, therefore, allow best outcomes. The book weaves skills in human-centered design into the design of medicinal delivery systems. It would be a reference for those in academia studying pharmacokinetics, formulation or product design and development, as well as those in the development of biopharmaceutical therapies. This is an open access book. This open access book builds the case for the business motivation, techniques, and approaches to use in development of a medicinal product for human therapy, whether delivered via an oral dose form (pill or solution) or a delivery system (device). Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

  • Langue : anglais

    Edité par HARVARD UNIV PR, 1968

    0674453018 / 9780674453012

    • Couverture rigide
    • Édition originale

    Vendeur : Roland Antiquariat UG haftungsbeschränkt, Weinheim, AllemagneRoland Antiquariat UG haftungsbeschränkt

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Occasion

    EUR 24,90

    EUR 42,00 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 1 disponible

    Hardcover. 1st Edition. 388 Seiten Good condition. Reading pages are clean and without marks. Retired library exemplar, with the usual marking. Corners slightly rubbed or bumped. 9780674453012 Sprache: Englisch Gewicht in Gramm: 770.

  • Langue : anglais

    Edité par Springer, 2025

    3031982525 / 9783031982521

    • Couverture rigide

    Vendeur : California Books, Miami, FL, Etats-UnisCalifornia Books

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 74,02

    EUR 2,73 expédition 
    Expédition nationale : Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Etat : New.

  • Langue : anglais

    Edité par Harvard University Press, 2014

    0674421752 / 9780674421752

    • Couverture rigide

    Vendeur : Home-set, Mannheim, AllemagneHome-set

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 48,00

    EUR 49,90 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 2 disponibles

    Gebundene Ausgabe. Etat : Neu. Neuware, Lieferung aus Deutschland. Sprache: Englisch Gewicht in Gramm: 708.

  • Langue : anglais

    Edité par Springer Nature, 2025

    3031982525 / 9783031982521

    • Couverture rigide

    Vendeur : Revaluation Books, Exeter, Royaume-UniRevaluation Books

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 89,77

    EUR 12,01 expédition 
    Expédition depuis Royaume-Uni vers Etats-Unis

    Quantité disponible : 2 disponibles

    Hardcover. Etat : Brand New. 149 pages. 9.26x6.11x9.25 inches. In Stock.

  • Langue : anglais

    Edité par Springer, 2025

    3031982525 / 9783031982521

    • Couverture rigide

    Vendeur : Books Puddle, Woodside, NY, Etats-UnisBooks Puddle

    Vendeur avec une évaluation de 4 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 101,20

    EUR 3,63 expédition 
    Expédition nationale : Etats-Unis

    Quantité disponible : 4 disponibles

    Etat : New.

  • Langue : anglais

    Edité par Springer, 2025

    3031982525 / 9783031982521

    • Couverture rigide

    Vendeur : AHA-BUCH GmbH, Einbeck, AllemagneAHA-BUCH GmbH

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 67,23

    EUR 35,00 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 1 disponible

    Buch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - This open access book builds the case for the business motivation, techniques, and approaches to use in development of a medicinal product for human therapy, whether delivered via an oral dose form ('pill' or solution) or a delivery system (device). It shares the growing demands by patients and caregivers, as well as regulators, for designs which are most easily understood and usable, and which can ensure the medication can be consistently delivered and will, therefore, allow best outcomes. The book weaves skills in 'human-centered design' into the design of medicinal delivery systems. It would be a reference for those in academia studying pharmacokinetics, formulation or product design and development, as well as those in the development of biopharmaceutical therapies. This is an open access book.…

  • Langue : anglais

    Edité par Springer, 2025

    3031982525 / 9783031982521

    • Couverture rigide

    Vendeur : Home-set, Mannheim, AllemagneHome-set

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 66,86

    EUR 49,90 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 2 disponibles

    Gebundene Ausgabe. Etat : Neu. This open access book builds the case for the business motivation, techniques, and approaches to use in development of a medicinal product for human therapy, whether delivered via an oral dose form ("pill" or solution) or a delivery system (device). It shares the growing demands by patients and caregivers, as well as regulators, for designs which are most easily understood and usable, and which can ensure the medication can be consistently delivered and will, therefore, allow best outcomes. The book weaves skills in "human-centered design" into the design of medicinal delivery systems. It would be a reference for those in academia studying pharmacokinetics, formulation or product design and development, as well as those in the development of biopharmaceutical therapies. This is an open access book. Sprache: Englisch Gewicht in Gramm: 349.…

  • Langue : anglais

    Edité par Springer International Publishing AG, Cham, 2025

    3031982525 / 9783031982521

    • Couverture rigide

    Vendeur : AussieBookSeller, Truganina, VIC, AustralieAussieBookSeller

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 95,27

    EUR 33,66 expédition 
    Expédition depuis Australie vers Etats-Unis

    Quantité disponible : 1 disponible

    Hardcover. Etat : new. Hardcover. This open access book builds the case for the business motivation, techniques, and approaches to use in development of a medicinal product for human therapy, whether delivered via an oral dose form (pill or solution) or a delivery system (device). It shares the growing demands by patients and caregivers, as well as regulators, for designs which are most easily understood and usable, and which can ensure the medication can be consistently delivered and will, therefore, allow best outcomes. The book weaves skills in human-centered design into the design of medicinal delivery systems. It would be a reference for those in academia studying pharmacokinetics, formulation or product design and development, as well as those in the development of biopharmaceutical therapies. This is an open access book. This open access book builds the case for the business motivation, techniques, and approaches to use in development of a medicinal product for human therapy, whether delivered via an oral dose form (pill or solution) or a delivery system (device). Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.…

  • Langue : anglais

    Edité par Springer, 2021

    3030314170 / 9783030314170

    Série : Livre 35 sur 38 - AAPS Advances in the Pharmaceutical Sciences

    • Couverture souple

    Vendeur : GreatBookPrices, Columbia, MD, Etats-UnisGreatBookPrices

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 253,33

    EUR 2,40 expédition 
    Expédition nationale : Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Etat : New.

  • Langue : anglais

    Edité par Springer, 2021

    3030314170 / 9783030314170

    Série : Livre 35 sur 38 - AAPS Advances in the Pharmaceutical Sciences

    • Couverture souple

    Vendeur : GreatBookPricesUK, Woodford Green, Royaume-UniGreatBookPricesUK

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 247,93

    EUR 18,02 expédition 
    Expédition depuis Royaume-Uni vers Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Etat : New.

  • Langue : anglais

    Edité par Springer, 2021

    3030314170 / 9783030314170

    Série : Livre 35 sur 38 - AAPS Advances in the Pharmaceutical Sciences

    • Couverture souple

    Vendeur : GreatBookPrices, Columbia, MD, Etats-UnisGreatBookPrices

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Occasion - Comme neuf

    EUR 290,58

    EUR 2,40 expédition 
    Expédition nationale : Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Etat : As New. Unread book in perfect condition.

  • Langue : anglais

    Edité par Springer, 2021

    3030314170 / 9783030314170

    Série : Livre 35 sur 38 - AAPS Advances in the Pharmaceutical Sciences

    • Couverture souple

    Vendeur : GreatBookPricesUK, Woodford Green, Royaume-UniGreatBookPricesUK

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Occasion - Comme neuf

    EUR 287,90

    EUR 18,02 expédition 
    Expédition depuis Royaume-Uni vers Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Etat : As New. Unread book in perfect condition.

  • Langue : anglais

    Edité par Springer, 2020

    3030314146 / 9783030314149

    Série : Livre 35 sur 38 - AAPS Advances in the Pharmaceutical Sciences

    • Couverture rigide

    Vendeur : Ria Christie Collections, Uxbridge, Royaume-UniRia Christie Collections

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 285,54

    EUR 22,02 expédition 
    Expédition depuis Royaume-Uni vers Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Etat : New. In English.

  • Langue : anglais

    Edité par Springer, 2021

    3030314170 / 9783030314170

    Série : Livre 35 sur 38 - AAPS Advances in the Pharmaceutical Sciences

    • Couverture souple

    Vendeur : Ria Christie Collections, Uxbridge, Royaume-UniRia Christie Collections

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 285,54

    EUR 22,02 expédition 
    Expédition depuis Royaume-Uni vers Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Etat : New. In English.

  • Langue : anglais

    Edité par Springer, 2020

    3030314146 / 9783030314149

    Série : Livre 35 sur 38 - AAPS Advances in the Pharmaceutical Sciences

    • Couverture rigide

    Vendeur : GreatBookPrices, Columbia, MD, Etats-UnisGreatBookPrices

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 305,87

    EUR 2,40 expédition 
    Expédition nationale : Etats-Unis

    Quantité disponible : 15 disponibles

    Etat : New.

  • Langue : anglais

    Edité par Springer International Publishing, 2021

    3030314170 / 9783030314170

    Série : Livre 35 sur 38 - AAPS Advances in the Pharmaceutical Sciences

    • Couverture souple

    Vendeur : moluna, Greven, Allemagnemoluna

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 250,30

    EUR 48,99 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Kartoniert / Broschiert. Etat : New.

  • Langue : anglais

    Edité par Springer International Publishing, 2020

    3030314146 / 9783030314149

    Série : Livre 35 sur 38 - AAPS Advances in the Pharmaceutical Sciences

    • Couverture rigide

    Vendeur : moluna, Greven, Allemagnemoluna

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 250,30

    EUR 48,99 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Gebunden. Etat : New.

  • Langue : anglais

    Edité par Springer Nature Switzerland AG, CH, 2021

    3030314170 / 9783030314170

    Série : Livre 35 sur 38 - AAPS Advances in the Pharmaceutical Sciences

    • Couverture souple

    Vendeur : Rarewaves.com USA, London, LONDO, Royaume-UniRarewaves.com USA

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 327,86

     Frais de port gratuits 
    Expédition depuis Royaume-Uni vers Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Paperback. Etat : New. 2020 ed. The biotechnology/biopharmaceutical sector has tremendously grown which led to the invention of engineered antibodies such as Antibody Drug Conjugates (ADCs), Bispecific T-cell engager (BITES), Dual Variable Domain (DVD) antibodies, and fusion proteins that are currently being used as therapeutic agents for immunology, oncology and other disease conditions. Regulatory agencies have raised the bar for the development and manufacture of antibody-based products, expecting to see the use of Quality by Design (QbD) elements demonstrating an in-depth understanding of product and process based on sound science. Drug delivery systems have become an increasingly important part of the therapy and most biopharmaceuticals for self-administration are being marketed as combination products. A survey of the market indicates that there is a strong need for a new book that will provide "one stop shopping" for the latest information and knowledge of the scientific and engineering advances madeover the last few years in the area of biopharmaceutical product development. The new book entitled Development of Biopharmaceutical Drug Device Products is a reference text for scientists and engineers in the biopharmaceutical industry, academia or regulatory agencies. With insightful chapters from experts in the field, this new book reviews first principles, covers recent technological advancements and provides case studies and regulatory strategies relating to the development and manufacture of antibody-based products.  It covers topics such as the importance of early preformulation studies during drug discovery to influence molecular selection for development, formulation strategies for new modalities, and the analytical techniques used to characterize them.  It also addresses important considerations for later stage development such as the development of robust formulations and processes, including process engineering and modeling of manufacturing unit operations, the design of analytical comparability studies, and characterization of primary containers (pre-filled syringes and vials).Finally, the latter half of the book reviews key considerations to ensure the development and approval of a patient-centered delivery system design. This involves the evolving regulatory framework with perspectives from both the US and EU industry experts, the role of international standards, design control/risk management, human factors and its importance in the product development and regulatory approval process, as well as review of the risk-based approach to bridging between devices used in clinical trials and the to-be-marketed device.  Finally, case studies are provided throughout.The typical readership would have biology and/or engineering degrees and would include researchers, scientific leaders, industry specialists and technology developers working in the biopharmaceutical field.…

  • Autres images

    Langue : anglais

    Edité par Springer, 2021

    3030314170 / 9783030314170

    Série : Livre 35 sur 38 - AAPS Advances in the Pharmaceutical Sciences

    • Couverture souple

    Vendeur : preigu, Osnabrück, Allemagnepreigu

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 256,95

    EUR 70,00 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 5 disponibles

    Taschenbuch. Etat : Neu. Development of Biopharmaceutical Drug-Device Products | Feroz Jameel (u. a.) | Taschenbuch | AAPS Advances in the Pharmaceutical Sciences Series | xviii | Englisch | 2021 | Springer | EAN 9783030314170 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu. …

  • Langue : anglais

    Edité par Springer, 2020

    3030314146 / 9783030314149

    Série : Livre 35 sur 38 - AAPS Advances in the Pharmaceutical Sciences

    • Couverture rigide

    Vendeur : California Books, Miami, FL, Etats-UnisCalifornia Books

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 353,24

    EUR 2,73 expédition 
    Expédition nationale : Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Etat : New.

  • Langue : anglais

    Edité par Springer, 2020

    3030314146 / 9783030314149

    Série : Livre 35 sur 38 - AAPS Advances in the Pharmaceutical Sciences

    • Couverture rigide

    Vendeur : GreatBookPrices, Columbia, MD, Etats-UnisGreatBookPrices

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Occasion - Comme neuf

    EUR 362,37

    EUR 2,40 expédition 
    Expédition nationale : Etats-Unis

    Quantité disponible : 15 disponibles

    Etat : As New. Unread book in perfect condition.

  • Langue : anglais

    Edité par Springer, 2021

    3030314170 / 9783030314170

    Série : Livre 35 sur 38 - AAPS Advances in the Pharmaceutical Sciences

    • Couverture souple

    Vendeur : AHA-BUCH GmbH, Einbeck, AllemagneAHA-BUCH GmbH

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 336,13

    EUR 44,46 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 1 disponible

    Taschenbuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - The biotechnology/biopharmaceutical sector has tremendously grown which led to the invention of engineered antibodies such as Antibody Drug Conjugates (ADCs), Bispecific T-cell engager (BITES), Dual Variable Domain (DVD) antibodies, and fusion proteins that are currently being used as therapeutic agents for immunology, oncology and other disease conditions. Regulatory agencies have raised the bar for the development and manufacture of antibody-based products, expecting to see the use of Quality by Design (QbD) elements demonstrating an in-depth understanding of product and process based on sound science. Drug delivery systems have become an increasingly important part of the therapy and most biopharmaceuticals for self-administration are being marketed as combination products. A survey of the market indicates that there is a strong need for a new book that will provide 'one stop shopping' for the latest information and knowledge of the scientific and engineering advances madeover the last few years in the area of biopharmaceutical product development. The new book entitled Development of Biopharmaceutical Drug Device Products is a reference text for scientists and engineers in the biopharmaceutical industry, academia or regulatory agencies.With insightful chapters from experts in the field, this new book reviews first principles, covers recent technological advancements and provides case studies and regulatory strategies relating to the development and manufacture of antibody-based products. It covers topics such as the importance of early preformulation studies during drug discovery to influence molecular selection for development, formulation strategies for new modalities, and the analytical techniques used to characterize them. It also addresses important considerations for later stage development such as the development of robust formulations and processes, including process engineering and modeling of manufacturing unit operations, the design of analytical comparability studies, and characterization of primary containers (pre-filled syringes and vials).Finally, the latter half of the book reviews key considerations to ensure the development and approval of a patient-centered delivery system design. This involves the evolving regulatory framework with perspectives from both the US and EU industry experts, the role of international standards, design control/risk management, human factors and its importance in the product development and regulatory approval process, as well as review of the risk-based approach to bridging between devices used in clinical trials and the to-be-marketed device. Finally, case studies are provided throughout.The typical readership would have biology and/or engineering degrees and would include researchers, scientific leaders, industry specialists and technology developers working in the biopharmaceutical field. …

  • Langue : anglais

    Edité par Springer Nature Switzerland AG, CH, 2021

    3030314170 / 9783030314170

    Série : Livre 35 sur 38 - AAPS Advances in the Pharmaceutical Sciences

    • Couverture souple

    Vendeur : Rarewaves.com UK, London, Royaume-UniRarewaves.com UK

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 315,00

    EUR 78,08 expédition 
    Expédition depuis Royaume-Uni vers Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Paperback. Etat : New. 2020 ed. The biotechnology/biopharmaceutical sector has tremendously grown which led to the invention of engineered antibodies such as Antibody Drug Conjugates (ADCs), Bispecific T-cell engager (BITES), Dual Variable Domain (DVD) antibodies, and fusion proteins that are currently being used as therapeutic agents for immunology, oncology and other disease conditions. Regulatory agencies have raised the bar for the development and manufacture of antibody-based products, expecting to see the use of Quality by Design (QbD) elements demonstrating an in-depth understanding of product and process based on sound science. Drug delivery systems have become an increasingly important part of the therapy and most biopharmaceuticals for self-administration are being marketed as combination products. A survey of the market indicates that there is a strong need for a new book that will provide "one stop shopping" for the latest information and knowledge of the scientific and engineering advances madeover the last few years in the area of biopharmaceutical product development. The new book entitled Development of Biopharmaceutical Drug Device Products is a reference text for scientists and engineers in the biopharmaceutical industry, academia or regulatory agencies. With insightful chapters from experts in the field, this new book reviews first principles, covers recent technological advancements and provides case studies and regulatory strategies relating to the development and manufacture of antibody-based products.  It covers topics such as the importance of early preformulation studies during drug discovery to influence molecular selection for development, formulation strategies for new modalities, and the analytical techniques used to characterize them.  It also addresses important considerations for later stage development such as the development of robust formulations and processes, including process engineering and modeling of manufacturing unit operations, the design of analytical comparability studies, and characterization of primary containers (pre-filled syringes and vials).Finally, the latter half of the book reviews key considerations to ensure the development and approval of a patient-centered delivery system design. This involves the evolving regulatory framework with perspectives from both the US and EU industry experts, the role of international standards, design control/risk management, human factors and its importance in the product development and regulatory approval process, as well as review of the risk-based approach to bridging between devices used in clinical trials and the to-be-marketed device.  Finally, case studies are provided throughout.The typical readership would have biology and/or engineering degrees and would include researchers, scientific leaders, industry specialists and technology developers working in the biopharmaceutical field.…